HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells.

Abstract
Bastadin 6, a macrocyclic tetramer of a brominated tyrosine derivative, was isolated from a marine sponge and its anti-angiogenic activity was evaluated. Bastadin 6 was found to inhibit vascular endothelial growth factor (VEGF)- or basic fibroblast growth factor (bFGF)-dependent proliferation (IC50=0.052 micromol/l) of human umbilical vein endothelial cells (HUVECs) 20- to 100-fold selectively in comparison with normal fibroblast (3Y1) or several tumor cells (KB3-1, K562 and Neuro2A). Bastadin 6 also inhibited VEGF- or bFGF-induced tubular formation (0.1 micromol/l, 6 h treatment) and VEGF-induced migration (1 micromol/l, 4 h treatment) of HUVECs. Moreover, bastadin 6 almost completely blocked VEGF- or bFGF-induced in vivo neovascularization in the mice corneal assay and suppressed growth of s.c. inoculated A431 solid tumor in nude mice (100 mg/kg, i.p.). Bastadin 6 induced cell death of HUVECs with an apoptotic phenotype, whereas it showed no effect on the VEGF-induced auto-phosphorylation of VEGF receptors Flt-1 and KDR/Flk-1. These results suggest that the anti-angiogenic effect of bastadin 6 is closely related to selective induction activity of apoptosis against endothelial cells.
AuthorsShunji Aoki, Seok-hwan Cho, Mayumi Ono, Takashi Kuwano, Shintaro Nakao, Michihiko Kuwano, Shinsaku Nakagawa, Jian-Qing Gao, Tadanori Mayumi, Masabumi Shibuya, Motomasa Kobayashi
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 17 Issue 3 Pg. 269-78 (Mar 2006) ISSN: 0959-4973 [Print] England
PMID16520655 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiogenesis Inhibitors
  • Halogenated Diphenyl Ethers
  • Vascular Endothelial Growth Factor A
  • bastadin 6
  • Fibroblast Growth Factor 2
  • Tyrosine
  • Vascular Endothelial Growth Factor Receptor-1
  • Vascular Endothelial Growth Factor Receptor-2
Topics
  • Angiogenesis Inhibitors (pharmacology)
  • Animals
  • Apoptosis (drug effects)
  • Carcinoma, Squamous Cell (blood supply, drug therapy)
  • Cell Growth Processes (drug effects)
  • Cornea (blood supply)
  • Endothelial Cells (cytology, drug effects)
  • Fibroblast Growth Factor 2 (antagonists & inhibitors, pharmacology)
  • Halogenated Diphenyl Ethers
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • NIH 3T3 Cells
  • Neovascularization, Pathologic (drug therapy, pathology)
  • Neovascularization, Physiologic (drug effects)
  • Porifera (chemistry)
  • Rats
  • Tyrosine (analogs & derivatives, pharmacology)
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors, blood, pharmacology)
  • Vascular Endothelial Growth Factor Receptor-1 (metabolism)
  • Vascular Endothelial Growth Factor Receptor-2 (metabolism)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: